These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4390515)

  • 1. Relative "strength" of histocompatibility barriers as compared on the basis of different criteria.
    Lengerová A; Viklický V
    Folia Biol (Praha); 1969; 15(5):333-9. PubMed ID: 4390515
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of histocompatibility barriers in congenic mice.
    Cantrell JL; Hildemann WH
    Transplant Proc; 1973 Mar; 5(1):271-4. PubMed ID: 4144458
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic strength of non-H-2 systems in mice.
    Micková M; Iványi P
    Folia Biol (Praha); 1969; 15(5):395-6. PubMed ID: 4390516
    [No Abstract]   [Full Text] [Related]  

  • 4. [Various effects of heterologous antithymus- and antilymphocyte serum on the development of the graft-vs-host reaction].
    Biege G; von Broen B
    Exp Pathol (Jena); 1970; 4(4):211-6. PubMed ID: 4399294
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor-recipient pairing for transplantation: present limitations and future objectives.
    Bach FH
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):141-3. PubMed ID: 4392666
    [No Abstract]   [Full Text] [Related]  

  • 6. Histocompatibility antigens on mouse spermatozoa.
    Vojtísková M; Polácková M; Pokorná Z
    Folia Biol (Praha); 1969; 15(5):322-32. PubMed ID: 4390514
    [No Abstract]   [Full Text] [Related]  

  • 7. The abolition of tolerance of skin homografts in rats with isoantiserum.
    Lubaroff DM; Silvers WK
    J Immunol; 1970 May; 104(5):1236-41. PubMed ID: 4392711
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation of the capacity of skin-specific alloantigens to elicit graft-versus-host reactions in the mouse.
    Fleming HL; Elkins WL; Silvers WK
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1223-5. PubMed ID: 7022929
    [No Abstract]   [Full Text] [Related]  

  • 9. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative strength of the male-specific antigen.
    Polácková M; Rejzková J; Viklický V
    Folia Biol (Praha); 1970; 16(6):381-4. PubMed ID: 4394678
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum.
    Floersheim GL; Brune K
    Transplant Proc; 1971 Mar; 3(1):688-92. PubMed ID: 4398510
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance and enhancement in organ transplantation.
    Brent L
    Transplant Proc; 1972 Sep; 4(3):363-8. PubMed ID: 4404151
    [No Abstract]   [Full Text] [Related]  

  • 13. Histocompatibility in humans.
    Fotino M
    Ann Clin Lab Sci (1971); 1971; 1(2):125-30. PubMed ID: 4405210
    [No Abstract]   [Full Text] [Related]  

  • 14. The frequency of "Allocluster-forming cells" in the lymph nodes of skin-grafted mice as a function of the histocompatibility barrier.
    Viklický V; Lengerová A; Matousek V; Doubelík M
    Folia Biol (Praha); 1971; 17(3):156-62. PubMed ID: 4397944
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of rat renal allograft enhancement by antigen and antibody.
    Stuart FP; Saitoh T; Logio T; Bastien E; Fitch FW
    Surg Forum; 1969; 20():278-81. PubMed ID: 4392724
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte environment and the durability of transplantation tolerance.
    Levey RH
    Transplant Proc; 1972 Sep; 4(3):395-9. PubMed ID: 4404152
    [No Abstract]   [Full Text] [Related]  

  • 17. Antilymphocyte serum and the induction of tolerance to transplantation antigens.
    Lance EM; Medawar PB
    Fed Proc; 1970; 29(1):151-2. PubMed ID: 4391648
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. Role of class I and class II major histocompatibility complex.
    Sheng-Tanner XF; Miller RG
    Transplantation; 1994 Apr; 57(7):1081-7. PubMed ID: 8165707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strength of H-2 and non-H-2 antigens as compared in ALS-suppressed recipients.
    Hilgert I; Nouza K
    Folia Biol (Praha); 1970; 16(6):369-73. PubMed ID: 4394676
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of allogeneic unresponsiveness by supralethal irradiation and bone marrow reconstitution.
    Rapaport FT; Bachvaroff RJ; Akiyama N; Sato T
    Transplant Proc; 1980 Sep; 12(3):473-6. PubMed ID: 7013179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.